Revenue of $290.3 million in Q3, up 2.7% versus prior yearDiluted EPS of $1.22 in Q3 increased approximately 15% versus prior ...

SAB BIO, (“SAB BIO”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression ...

A live webcast of the fireside chat can be accessed by visiting the Events and Presentations section of the Company’s website: https://ir.protaratx.com. The webcast will be archived for a limited time ...

The fireside chat will be webcasted and available under “Events & Presentations” in the Investor Relations section of the Company’s website at www.rhythmtx.com. A replay of the webcast will be ...

Trusted resource of information on Emergency Medicine that includes news, articles, medical conditions, medications, ...

The Oral Health Section of The Department of Health will hold its inaugural Bermuda Oral Health Symposium, on February 6 and ...

Hospital for Special Surgery (HSS), the world's leading academic medical center focused on musculoskeletal health, today ...